title: Severe hypertension after initiation of rifapentine/isoniazid for latent tuberculosis in renal transplant candidates.
authors.affiliation: Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, FL, USA.
authors.forename: Jacques
authors.initials: J
authors.lastname: Simkins
authors.affiliation: Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, FL, USA.
authors.forename: Michele I
authors.initials: MI
authors.lastname: Morris
authors.affiliation: Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, FL, USA.
authors.forename: Lilian M
authors.initials: LM
authors.lastname: Abbo
authors.affiliation: Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, FL, USA.
authors.forename: Jose F
authors.initials: JF
authors.lastname: Camargo
mesh_terms: D000328:Adult; D000368:Aged; D000995:Antitubercular Agents / Q000009:adverse effects*; D001794:Blood Pressure; D015331:Cohort Studies; D004359:Drug Therapy, Combination; D006801:Humans; D006973:Hypertension / Q000139:chemically induced*; D007538:Isoniazid / Q000008:administration & dosage*; D016030:Kidney Transplantation; D055985:Latent Tuberculosis / Q000188:drug therapy*; D008875:Middle Aged; D012293:Rifampin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D013997:Time Factors; D066027:Transplant Recipients
chemical_list: D000995:Antitubercular Agents; D007538:Isoniazid; D012293:Rifampin; C018421:rifapentine